|
In February, FDA
proposed the inclusion of larger graphics, simplified language (for example,
"lung" instead of "pulmonary") and more prominent
warnings on over-the-counter drugs. If adopted, the new requirements could
also become part of dietary supplement label guidelines. Manufacturers
of OTC drugs have four months to respond to the label proposal. The FDA
believes the labeling changes will make comparison shopping easier and
reduce adverse reactions. Manufacturers would have two years to comply;
smaller companies would be given up to three years. |
|